Luminex (Canada)

Recent papers from Luminex (Canada)

1. Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaAdvances in Therapy · 2026
2. Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment Comparison.2026
3. A-367 Rapid and Sensitive Real-time RT-PCR Point-of-Care System for Detection and Differentiation of Influenza A and B, RSV, and SARS-CoV-2Clinical Chemistry · 2025
4. 39‐2: Invited Paper: Sampled Analog Driving of High Frame‐Rate UHD DisplaysSID Symposium Digest of Technical Papers · 2025
5. Canadian College of Medical Geneticists: clinical practice advisory document – responsibility to recontact for reinterpretation of clinical genetic testingJournal of Medical Genetics · 2024
6. Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panelAnnals of the New York Academy of Sciences · 2011
7. A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community-Acquired Respiratory Viruses in Lung Transplant RecipientsTransplantation · 2010
8. The Escherichia coli Mismatch Repair Protein MutL Recruits the Vsr and MutH Endonucleases in Response to DNA DamageJournal of Bacteriology · 2009
9. Estimation of Warfarin Maintenance Dose Based on VKORC1 (−1639 G>A) and CYP2C9 GenotypesClinical Chemistry · 2007